Recent Updates
Recently added Catalysts
BLTE Positive Sentiment Score: 70/100

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Monday, May 13, 2024 1 min read
Key Takeaway: Belite Bio, Inc. (NASDAQ: BLTE) announced its participation in the H.C. Wainwright 2nd Annual BioConnect Investor Conference on May 20, 2024, in New York. The company will host a fireside chat at 3:30 pm ET, focusing on its clinical-stage biopharmaceutical drug developments. This appearance underscores the company's ongoing efforts to advance its novel therapeutics targeting degenerative retinal diseases. A webcast of the session will be available on their investor relations page.

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is advancing novel therapeutics for degenerative retinal diseases.
  • The participation in a prestigious investor conference indicates growth and interest.
  • The company is addressing significant unmet medical needs in the pharmaceutical market.

Full Press Release Details

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference being held in New York, NY, on May 20, 2024. The Company will host a fireside chat at 3:30 pm ET.
A webcast of the fireside chat can be accessed under the "Events" tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replay will be archived for 90 days following the presentation date.
Media and Investor Relations Contact:
belite@argotpartners.com

Frequently Asked Questions

When is Belite Bio participating in the BioConnect Investor Conference?

Belite Bio will participate on May 20, 2024.

What time is Belite Bio's fireside chat scheduled for?

The fireside chat is set for 3:30 pm ET.

Where can I access the webcast of the fireside chat?

The webcast is available on the Belite Bio investor relations website.

How long will the replay of the fireside chat be available?

The replay will be archived for 90 days after the event.

What is Belite Bio focused on developing?

Belite Bio focuses on therapeutics for degenerative retinal diseases.

Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio retinal diseases investor conference biopharmaceuticals
Last updated: May 13, 2024